Mirapulse is a women’s health technology company founded in 2021, dedicated to transforming chronic pain management through science-backed, user-centered innovation. Its flagship product, EVA, is a discreet and portable device that offers real-time pain relief using Intravaginal Electrical Stimulation (IVES)—a groundbreaking technology that delivers controlled electrical impulses to stimulate nerves and interrupt pain signals to the brain. Unlike surface-level solutions, EVA’s internal placement enables targeted nerve stimulation, broader pelvic nerve coverage for complex conditions such as endometriosis, and lower tissue impedance, allowing for more effective and precise analgesic current conduction. Designed for use at home, at work, or on the go, EVA empowers women with greater autonomy and comfort in managing chronic pelvic pain. Mirapulse’s mission is to reimagine women’s pain care with empathy, evidence, and innovation—putting control back in the hands of those who need it most.